Shanghai Pharmaceuticals Holding Co Ltd Cash Flow Quality Index
Shanghai Pharmaceuticals Holding Co Ltd cash flow quality index. Shanghai Pharmaceuticals Holding Co Ltd (601607) has a Cash Flow Quality Index of 2.26x as of September 2025. Operating cash flow of CN¥1.56 Billion exceeds net income of CN¥688.20 Million, indicating high earnings quality where cash backs reported profits. See 601607 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Shanghai Pharmaceuticals Holding Co Ltd (1998–2025)
Cash flow quality index of Shanghai Pharmaceuticals Holding Co Ltd from 1998 to 2025. Historical Cash Flow Quality Index for Shanghai Pharmaceuticals Holding Co Ltd across 28 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 601607 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Shanghai Pharmaceuticals Holding Co Ltd Cash Flow Quality Index by Year (1998–2025)
Shanghai Pharmaceuticals Holding Co Ltd cash flow quality index by year from 1998 to 2025. Year-by-year earnings quality comparison for Shanghai Pharmaceuticals Holding Co Ltd. For the full cash flow conversion analysis, see Shanghai Pharmaceuticals Holding Co Ltd operating cash flow efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.08x | CN¥6.15 Billion | CN¥5.72 Billion | ▲ +8.3% |
| 2024 | 0.99x | CN¥5.83 Billion | CN¥5.87 Billion | ▼ -28.5% |
| 2023 | 1.39x | CN¥5.23 Billion | CN¥3.77 Billion | ▲ +104.7% |
| 2022 | 0.68x | CN¥4.74 Billion | CN¥6.99 Billion | ▼ -15.9% |
| 2021 | 0.81x | CN¥5.06 Billion | CN¥6.27 Billion | ▼ -33.9% |
| 2020 | 1.22x | CN¥6.84 Billion | CN¥5.61 Billion | ▼ -2.0% |
| 2019 | 1.25x | CN¥6.02 Billion | CN¥4.83 Billion | ▲ +77.2% |
| 2018 | 0.70x | CN¥3.14 Billion | CN¥4.46 Billion | ▲ +7.8% |
| 2017 | 0.65x | CN¥2.65 Billion | CN¥4.06 Billion | ▲ +28.4% |
| 2016 | 0.51x | CN¥1.95 Billion | CN¥3.83 Billion | ▲ +26.8% |
| 2015 | 0.40x | CN¥1.35 Billion | CN¥3.36 Billion | ▼ -10.2% |
| 2014 | 0.45x | CN¥1.34 Billion | CN¥2.99 Billion | ▲ +20.5% |
| 2013 | 0.37x | CN¥973.45 Million | CN¥2.63 Billion | ▼ -20.8% |
| 2012 | 0.47x | CN¥1.15 Billion | CN¥2.46 Billion | ▼ -35.5% |
| 2011 | 0.72x | CN¥1.77 Billion | CN¥2.45 Billion | ▼ -23.5% |
| 2010 | 0.95x | CN¥1.69 Billion | CN¥1.78 Billion | ▼ -62.4% |
| 2009 | 2.52x | CN¥664.13 Million | CN¥263.48 Million | ▲ +14.2% |
| 2008 | 2.21x | CN¥285.68 Million | CN¥129.43 Million | ▼ -56.9% |
| 2007 | 5.12x | CN¥488.94 Million | CN¥95.48 Million | ▼ -20.5% |
| 2006 | 6.44x | CN¥583.11 Million | CN¥90.54 Million | ▲ +529.9% |
| 2005 | 1.02x | CN¥73.00 Million | CN¥71.40 Million | ▲ +129.7% |
| 2004 | 0.45x | CN¥61.66 Million | CN¥138.51 Million | ▲ +18973.7% |
| 2003 | 0.00x | CN¥484.27K | CN¥207.48 Million | ▼ -99.6% |
| 2002 | 0.62x | CN¥100.84 Million | CN¥163.07 Million | ▲ +64.4% |
| 2001 | 0.38x | CN¥65.73 Million | CN¥174.77 Million | ▼ -47.4% |
| 2000 | 0.71x | CN¥146.22 Million | CN¥204.65 Million | ▼ -51.9% |
| 1999 | 1.49x | CN¥164.67 Million | CN¥110.84 Million | ▲ +147.1% |
| 1998 | -3.15x | CN¥-283.14 Million | CN¥89.83 Million | — |